Integra LifeSciences Holdings (IART)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 3.14% | 2.12% | 3.51% | 3.96% | 6.62% | 9.11% | 11.62% | 14.54% | 15.13% | 14.58% | 14.03% | 13.12% | 14.39% | 27.51% | 38.97% | 49.69% | 64.61% | 64.60% | 63.92% | 64.29% |
| Operating profit margin | 1.78% | 1.88% | 4.18% | 5.37% | 7.50% | 9.63% | 12.17% | 15.18% | 15.87% | 15.09% | 14.52% | 14.08% | 12.84% | 12.53% | 12.81% | 11.30% | 11.49% | 10.18% | 4.23% | 6.04% |
| Pretax margin | -1.14% | -0.78% | 1.78% | 3.13% | 5.45% | 7.82% | 10.48% | 13.53% | 14.21% | 13.26% | 12.73% | 12.36% | 13.98% | 13.20% | 12.80% | 10.89% | 7.10% | 6.12% | 0.90% | 3.19% |
| Net profit margin | -0.43% | -0.43% | 1.55% | 2.73% | 4.56% | 6.77% | 8.79% | 11.38% | 11.99% | 11.38% | 10.94% | 10.37% | 11.01% | 14.15% | 13.66% | 12.41% | 10.16% | 4.27% | -0.26% | 1.82% |
Integra LifeSciences Holdings has experienced a significant decline in profitability ratios over the past few years.
The Gross Profit Margin, which measures the proportion of revenue left after deducting the cost of goods sold, decreased from around 64% in March 2020 to approximately 3% by December 2024. This indicates a decrease in the company's ability to generate profits from its core operations.
The Operating Profit Margin, which shows the percentage of revenue that remains after deducting operating expenses, dropped from about 6% in March 2020 to roughly 2% by December 2024. This reflects a consistent decline in the company's operational efficiency and profitability.
The Pretax Margin, representing the proportion of revenue that translates into pre-tax income, decreased from around 3% in March 2020 to negative figures by December 2024. This suggests challenges in the company's ability to generate profits before accounting for taxes.
Finally, the Net Profit Margin, which indicates the percentage of revenue that turns into net profit, declined from approximately 2% in March 2020 to negative figures by December 2024. This signifies a significant decrease in the company's bottom line profitability.
Overall, the decreasing trend in all profitability ratios highlights the financial challenges faced by Integra LifeSciences Holdings, indicating a need for strategic changes to improve its profitability and financial performance.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 0.70% | 0.71% | 1.56% | 1.94% | 2.95% | 3.83% | 4.81% | 6.12% | 6.14% | 6.02% | 5.88% | 5.79% | 5.21% | 5.08% | 5.19% | 4.14% | 4.19% | 3.90% | 1.67% | 2.57% |
| Return on assets (ROA) | -0.17% | -0.16% | 0.58% | 0.99% | 1.79% | 2.70% | 3.47% | 4.59% | 4.64% | 4.54% | 4.43% | 4.26% | 4.47% | 5.73% | 5.54% | 4.55% | 3.70% | 1.64% | -0.10% | 0.77% |
| Return on total capital | 1.25% | 1.50% | 2.44% | 2.96% | 4.44% | 5.57% | 6.86% | 8.45% | 8.49% | 8.06% | 7.93% | 7.85% | 8.62% | 8.53% | 8.67% | 7.17% | 5.65% | 5.29% | 2.58% | 3.73% |
| Return on equity (ROE) | -0.45% | -0.43% | 1.54% | 2.52% | 4.27% | 6.39% | 7.80% | 10.26% | 10.01% | 10.03% | 10.01% | 9.69% | 10.04% | 13.26% | 13.05% | 11.12% | 8.84% | 4.04% | -0.26% | 1.98% |
Integra LifeSciences Holdings has shown fluctuations in profitability ratios over the given periods.
- Operating return on assets (Operating ROA) has generally improved over time, reaching its peak at 6.14% by December 31, 2022, before declining to 0.70% by December 31, 2024. This ratio indicates the company's ability to generate operating income relative to its total assets.
- Return on assets (ROA) shows a similar trend, peaking at 5.73% by September 30, 2021, before decreasing to -0.17% by December 31, 2024. ROA measures the company's profitability in relation to its total assets.
- Return on total capital peaked at 8.67% by June 30, 2021, and showed a general decrease thereafter to 1.25% by December 31, 2024. This ratio reflects the company's ability to generate returns for both debt and equity holders.
- Return on equity (ROE) followed a similar pattern, with the highest point at 13.26% by September 30, 2021, and declining to -0.45% by December 31, 2024. ROE indicates how well the company is utilizing shareholders' equity to generate profits.
Overall, the downward trends in these profitability ratios towards the end of the period may indicate potential challenges in generating profits and returns for the company. An in-depth analysis of the company's operations and financial strategies would be necessary to understand the underlying reasons for these trends.